Sir Run Run Shaw Hospital
People's Republic of China
- Country
- People's Republic of China
- Ownership
- Private
- Established
- 1994-01-01
- Employees
- -
- Market Cap
- -
Heterogeneity of Lung Ventilation Determined by EIT During PFT in Patients With PRISM
Recruiting
- Conditions
- COPD
- Interventions
- Diagnostic Test: pulmonary function test
- First Posted Date
- 2024-01-10
- Last Posted Date
- 2024-05-08
- Lead Sponsor
- Sir Run Run Shaw Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT06199258
- Locations
- 🇨🇳
Sir Run Run Shaw Hospital, Hangzhou, Zhejiang, China
Circulating Tumor DNA Methylation Guiding Postoperative Adjuvant Chemotherapy in Stage III Colorectal Cancer
Not Applicable
Recruiting
- Conditions
- Colorectal Cancer
- Interventions
- Diagnostic Test: standard treatmentDiagnostic Test: ctDNA methylation
- First Posted Date
- 2023-12-13
- Last Posted Date
- 2024-05-17
- Lead Sponsor
- Sir Run Run Shaw Hospital
- Target Recruit Count
- 990
- Registration Number
- NCT06167967
- Locations
- 🇨🇳
Sir Run Run Shao hospital, Hanzhou, Zhejiang, China
Comparison of Clinical Outcomes of Mini Midline Catheters With Different Placement Sites: a Randomized Controlled Trial
Not Applicable
Completed
- Conditions
- Catheter Complications
- Interventions
- Device: Mini Midline
- First Posted Date
- 2023-10-30
- Last Posted Date
- 2024-04-11
- Lead Sponsor
- Sir Run Run Shaw Hospital
- Target Recruit Count
- 130
- Registration Number
- NCT06106659
- Locations
- 🇨🇳
Linfang Zhao, Hangzhou, Zhejiang, China
Molecular Basis of Loss Aversion
Not Applicable
Recruiting
- Conditions
- Healthy
- Interventions
- Drug: single-dose madopar, single-dose placebo, and single-dose propranolol by orderDrug: single-dose propranolol, single-dose madopar, and single-dose placebo by orderDrug: single-dose propranolol, single-dose placebo, and single-dose madopar by orderDrug: single-dose placebo, single-dose propranolol, and single-dose madopar by orderDrug: single-dose madopar, single-dose propranolol, and single-dose placebo by orderDrug: single-dose placebo, single-dose madopar, and single-dose propranolol by order
- First Posted Date
- 2023-09-13
- Last Posted Date
- 2023-09-26
- Lead Sponsor
- Sir Run Run Shaw Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT06034158
- Locations
- 🇨🇳
Sir Run Run Shaw Hospital, Hangzhou, Zhejiang, China
An Exploratory Study of Perioperative Venous Access in Obese Patients
Not Applicable
Not yet recruiting
- Conditions
- Catheter Complications
- Interventions
- Other: Midline catheterOther: Long peripheral venous catheters for use
- First Posted Date
- 2023-09-11
- Last Posted Date
- 2023-09-11
- Lead Sponsor
- Sir Run Run Shaw Hospital
- Target Recruit Count
- 528
- Registration Number
- NCT06031545
- Locations
- 🇨🇳
Linfang Zhao, Hangzhou, Zhejiang, China
Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Subjects With Resected Digestive System Neoplasms
Phase 1
Recruiting
- Conditions
- Digestive System Neoplasms
- Interventions
- Biological: iNeo-Vac-R01 in combination with standard adjuvant therapy
- First Posted Date
- 2023-09-07
- Last Posted Date
- 2023-09-11
- Lead Sponsor
- Sir Run Run Shaw Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT06026774
- Locations
- 🇨🇳
Department of General Surgery, Institute of Minimally Invasive Surgery, Sir Run Run Shaw Hospital, Hangzhou, Zhejiang, China
Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Combination With Standard First-line Treatment in Subjects With Advanced Digestive System Neoplasms
Phase 1
Recruiting
- Conditions
- Digestive System Neoplasms
- Interventions
- Biological: iNeo-Vac-R01
- First Posted Date
- 2023-09-07
- Last Posted Date
- 2023-09-11
- Lead Sponsor
- Sir Run Run Shaw Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT06026800
- Locations
- 🇨🇳
Department of General Surgery, Institute of Minimally Invasive Surgery, Sir Run Run Shaw Hospital, Hangzhou, Zhejiang, China
Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen Alone in Subjects With Advanced Digestive System Neoplasms
Phase 1
Recruiting
- Conditions
- Digestive System Neoplasms
- Interventions
- Biological: iNeo-Vac-R01
- First Posted Date
- 2023-08-31
- Last Posted Date
- 2023-09-11
- Lead Sponsor
- Sir Run Run Shaw Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT06019702
- Locations
- 🇨🇳
Department of General Surgery, Institute of Minimally Invasive Surgery, Sir Run Run Shaw Hospital, Hangzhou, Zhejiang, China
Research on the Application of Blood Collection Through Midline Catheters of Different Lengths
Not Applicable
Not yet recruiting
- Conditions
- Catheter Complications
- Interventions
- Behavioral: Midline catheter for blood collectionBehavioral: Long peripheral venous catheters for blood collectionBehavioral: SPCs for blood collection
- First Posted Date
- 2023-08-28
- Last Posted Date
- 2023-10-25
- Lead Sponsor
- Sir Run Run Shaw Hospital
- Target Recruit Count
- 162
- Registration Number
- NCT06014099
- Locations
- 🇨🇳
Linfang Zhao, Hangzhou, Zhejiang, China
Nodes-sparing Short-course Radiation Combined With CAPOX and Tislelizumab for MSS Middle and Low Rectal Cancer
Phase 2
Recruiting
- Conditions
- Low Rectal Cancer
- Interventions
- First Posted Date
- 2023-08-02
- Last Posted Date
- 2025-01-09
- Lead Sponsor
- Sir Run Run Shaw Hospital
- Target Recruit Count
- 32
- Registration Number
- NCT05972655
- Locations
- 🇨🇳
Sir Run Run Shao hospital, Hanzhou, Zhejiang, China